Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 739.40
-42.90 (-5.48%)
May 15, 2026, 1:44 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 221.29 million as of May 15, 2026. Its market cap has decreased by -9.29% in one year.
Market Cap
221.29M
Enterprise Value
195.52M
Revenue
679.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
739.40
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 221.29M, a decrease of -81.65%. That is a compound annual growth rate of -31.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 221.29M | 21.44% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 119.33B |
| Danel (Adir Yeoshua) | 2.62B |
| Amal Holdings A.D. | 2.37B |
| BrainsWay | 1.85B |
| Ilex Medical | 525.84M |
| Bonus BioGroup | 476.60M |
| Novolog (Pharm-Up 1966) | 435.27M |
| Geffen Residence & Renewal | 334.87M |